165 related articles for article (PubMed ID: 26218146)
21. Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex: involvement in estrogen receptor alpha signaling pathway.
Prévôt D; Morel AP; Voeltzel T; Rostan MC; Rimokh R; Magaud JP; Corbo L
J Biol Chem; 2001 Mar; 276(13):9640-8. PubMed ID: 11136725
[TBL] [Abstract][Full Text] [Related]
22. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?
Tirone F
J Cell Physiol; 2001 May; 187(2):155-65. PubMed ID: 11267995
[TBL] [Abstract][Full Text] [Related]
23. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway.
Rouault JP; Falette N; Guéhenneux F; Guillot C; Rimokh R; Wang Q; Berthet C; Moyret-Lalle C; Savatier P; Pain B; Shaw P; Berger R; Samarut J; Magaud JP; Ozturk M; Samarut C; Puisieux A
Nat Genet; 1996 Dec; 14(4):482-6. PubMed ID: 8944033
[TBL] [Abstract][Full Text] [Related]
24. Targeted disruption in the mouse Hoxc-4 locus results in axial skeleton homeosis and malformation of the xiphoid process.
Saegusa H; Takahashi N; Noguchi S; Suemori H
Dev Biol; 1996 Feb; 174(1):55-64. PubMed ID: 8626021
[TBL] [Abstract][Full Text] [Related]
25. Regulation of Btg2(/TIS21/PC3) expression via reactive oxygen species-protein kinase C-ΝFκΒ pathway under stress conditions.
Imran M; Lim IK
Cell Signal; 2013 Dec; 25(12):2400-12. PubMed ID: 23876794
[TBL] [Abstract][Full Text] [Related]
26. Compound mutants for the paralogous hoxa-4, hoxb-4, and hoxd-4 genes show more complete homeotic transformations and a dose-dependent increase in the number of vertebrae transformed.
Horan GS; Ramírez-Solis R; Featherstone MS; Wolgemuth DJ; Bradley A; Behringer RR
Genes Dev; 1995 Jul; 9(13):1667-77. PubMed ID: 7628700
[TBL] [Abstract][Full Text] [Related]
27. B-cell translocation gene-2 increases hepatic gluconeogenesis via induction of CREB.
Hwang SL; Kwon O; Lee SJ; Roh SS; Kim YD; Choi JH
Biochem Biophys Res Commun; 2012 Nov; 427(4):801-5. PubMed ID: 23058912
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes.
Choi JA; Jung YS; Kim JY; Kim HM; Lim IK
Oncogene; 2016 Jan; 35(1):83-93. PubMed ID: 25798836
[TBL] [Abstract][Full Text] [Related]
29. Transformation of axial skeleton due to overexpression of bmi-1 in transgenic mice.
Alkema MJ; van der Lugt NM; Bobeldijk RC; Berns A; van Lohuizen M
Nature; 1995 Apr; 374(6524):724-7. PubMed ID: 7715727
[TBL] [Abstract][Full Text] [Related]
30. miR‑27a suppresses the clonogenic growth and migration of human glioblastoma multiforme cells by targeting BTG2.
Li WQ; Yu HY; Zhong NZ; Hou LJ; Li YM; He J; Liu HM; Xia CY; Lu YC
Int J Oncol; 2015 Apr; 46(4):1601-8. PubMed ID: 25626081
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of the BTG2 gene in TPA- or RA-treated HL-60 cell lines.
Cho BO; Jeong YW; Kim SH; Park K; Lee JH; Kweon GR; Park JC
Oncol Rep; 2008 Mar; 19(3):633-7. PubMed ID: 18288394
[TBL] [Abstract][Full Text] [Related]
32. Btg1 and Btg2 gene expression during early chick development.
Kamaid A; Giráldez F
Dev Dyn; 2008 Aug; 237(8):2158-69. PubMed ID: 18651656
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of bladder cancer invasion by Sp1-mediated BTG2 expression via inhibition of DNA methyltransferase 1.
Devanand P; Kim SI; Choi YW; Sheen SS; Yim H; Ryu MS; Kim SJ; Kim WJ; Lim IK
FEBS J; 2014 Dec; 281(24):5581-601. PubMed ID: 25284287
[TBL] [Abstract][Full Text] [Related]
34. Role of Btg2 in the progression of a PDGF-induced oligodendroglioma model.
Appolloni I; Curreli S; Caviglia S; Barilari M; Gambini E; Pagano A; Malatesta P
Int J Mol Sci; 2012 Nov; 13(11):14667-78. PubMed ID: 23203087
[TBL] [Abstract][Full Text] [Related]
35. BTG2 is an LXXLL-dependent co-repressor for androgen receptor transcriptional activity.
Hu XD; Meng QH; Xu JY; Jiao Y; Ge CM; Jacob A; Wang P; Rosen EM; Fan S
Biochem Biophys Res Commun; 2011 Jan; 404(4):903-9. PubMed ID: 21172304
[TBL] [Abstract][Full Text] [Related]
36. BTG2, its family and its tutor.
Duriez C; Moyret-Lalle C; Falette N; El-Ghissassi F; Puisieux A
Bull Cancer; 2004; 91(7-8):E242-53. PubMed ID: 15381462
[TBL] [Abstract][Full Text] [Related]
37. Tumor suppressor BTG1 promotes PRMT1-mediated ATF4 function in response to cellular stress.
Yuniati L; van der Meer LT; Tijchon E; van Ingen Schenau D; van Emst L; Levers M; Palit SA; Rodenbach C; Poelmans G; Hoogerbrugge PM; Shan J; Kilberg MS; Scheijen B; van Leeuwen FN
Oncotarget; 2016 Jan; 7(3):3128-43. PubMed ID: 26657730
[TBL] [Abstract][Full Text] [Related]
38. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway.
Li YJ; Dong BK; Fan M; Jiang WX
Int J Clin Exp Pathol; 2015; 8(10):12410-8. PubMed ID: 26722427
[TBL] [Abstract][Full Text] [Related]
39. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
Liu M; Wu H; Liu T; Li Y; Wang F; Wan H; Li X; Tang H
Cell Res; 2009 Jul; 19(7):828-37. PubMed ID: 19546886
[TBL] [Abstract][Full Text] [Related]
40. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D
Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]